Nang Kuang Pharmaceutical Co., Ltd. (1752.TW)

TWD 34.35

(0.15%)

Market Cap (In TWD)

3.46 Billion

Revenue (In TWD)

2.15 Billion

Net Income (In TWD)

198.4 Million

Avg. Volume

104.47 Thousand

Currency
TWD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
40.1-58.0
PE
14.31
EPS
2.4
Beta Value
0.238
ISIN
TW0001752004
CUSIP
-
CIK
-
Shares
100988000.0
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Ms. Yu-Bei Wang
Employee Count
-
Website
https://www.nangkuang.com.tw
Ipo Date
2022-01-20
Details
Nang Kuang Pharmaceutical Co., Ltd. operates as a pharmaceutical company primarily in Taiwan. The company provides parenterals, aseptic parenterals, lyophilized injections, pre-filled syringes, and pre-mixed IV infusion bags, as well as tablets, capsules, topical products, and oral suspensions. It offers various products in the areas of cardiovascular system, gastrointestinal system, nervous system, alimentary and metabolism, blood, antineoplastic and immunomodulatory, musculo-skeletal system, respiratory system, dermatological, genito-urinary and sex hormone, systemic hormone, systemic antibacterial, and cosmetics, as well as hospital solution. In addition, the company offers sterile, anticancer injectable, injectable controlled and oral controlled products, and oral disintegration tablets. Nang Kuang Pharmaceutical Co., Ltd. was founded in 1963 and is headquartered in Tainan City, Taiwan.